Hainan Huluwa Pharmaceutical Group (Ticker Symbol: 605199.SH) released its semi-annual report on August 28th. During the reporting period, the company achieved a revenue of 846.7141 million yuan, a decrease of 7.36% year-on-year. The net income attributable to shareholders of the listed company was 78.7516 million yuan, an increase of 28.33% year-on-year. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 42.19 million yuan, a decrease of 11.91% year-on-year.